IPCA-FRUSEMIDE furosemide (frusemide) 40 mg tablet bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

furosemide, Quantity: 40 mg

Disponible depuis:

Ipca Pharma (Australia) Pty Ltd

DCI (Dénomination commune internationale):

furosemide (frusemide)

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: sodium starch glycollate type A; maize starch; lactose monohydrate; magnesium stearate; pregelatinised maize starch

Mode d'administration:

Oral

Unités en paquet:

250, 100, 1000

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Oedema Frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. Frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,Parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. If gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. Parenteral use should be replaced with oral frusemide as soon as practical.,Hypertension Oral Frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

Descriptif du produit:

Visual Identification: White to off-white, round tablets, embossed 'F4' on one side and breakline on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2012-06-28

Notice patient

IPCA-FRUSEMIDE
CONSUMER MEDICINE INFORMATION JUNE 2023 VERSION 1.3
COMMERCIAL-IN-CONFIDENCE
1
Contains the active ingredient Frusemide
WHAT IS IN THIS LEAFLET
READ THIS LEAFLET CAREFULLY BEFORE TAKING YOUR MEDICINE.
This leaflet answers some common questions about frusemide. It does
not contain all the
available information. It does not take the place of talking to your
doctor or pharmacist.
The information in this leaflet was last updated on the date listed on
the last page. More
recent information on this medicine may be available.
ASK YOUR DOCTOR OR PHARMACIST:
•
if there is anything you do not understand in this leaflet,
•
if you are worried about taking your medicine, or
•
to obtain the most up-to-date information.
All medicines have risks and benefits. Your doctor has weighed the
risks of you using this
medicine against the benefits they expect it will have for you.
Pharmaceutical companies cannot give you medical advice or an
individual diagnosis.
Keep this leaflet with your medicine.
You may want to read it again.
WHAT THIS MEDICINE IS USED FOR
The name of your medicine is
IPCA-FRUSEMIDE
. It contains the active ingredient frusemide.
Frusemide belongs to a family of drugs called diuretics. A diuretic
helps reduce the amount
of excess fluid in the body by increasing the amount of urine
produced.
Frusemide is used to treat swelling of the ankles, feet, legs or even
the brain or lungs. This
swelling is called oedema and can occur in some heart, lung, liver or
kidney conditions.
Frusemide may be used in some patients with more serious kidney
problems who may have
some fluid retention.
Frusemide
may
also
be
used
to
lower
high
blood
pressure
(which
is
also
called
hypertension).
Everyone has blood pressure. This pressure helps move your blood
around your body. Your
blood pressure may be different at different times of the day,
depending on how busy or
worried you are. You have hypertension (high blood pressure) when your
blood pressure
stays higher than is needed, even when you are calm and relaxed.
If hig